Valencia-Olvera AC - Search Results

1

Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation.

Valencia-Olvera AC, Balu D, Faulk N, Amiridis A, Wang Y, Pham C, Avila-Munoz E, York JM, Thatcher GRJ, LaDu MJ. Valencia-Olvera AC, et al. Neurotherapeutics. 2023 Jul;20(4):1120-1137. doi: 10.1007/s13311-023-01375-3. Epub 2023 May 8. Neurotherapeutics. 2023. PMID: 37157042 Free PMC article.

2

Rexinoids as Therapeutics for Alzheimer's Disease: Role of APOE.

Koster KP, Smith C, Valencia-Olvera AC, Thatcher GR, Tai LM, LaDu MJ. Koster KP, et al. Among authors: valencia olvera ac. Curr Top Med Chem. 2017;17(6):708-720. doi: 10.2174/1568026616666160617090227. Curr Top Med Chem. 2017. PMID: 27320328 Review.

3

EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.

Tai LM, Balu D, Avila-Munoz E, Abdullah L, Thomas R, Collins N, Valencia-Olvera AC, LaDu MJ. Tai LM, et al. Among authors: valencia olvera ac. J Lipid Res. 2017 Sep;58(9):1733-1755. doi: 10.1194/jlr.R076315. Epub 2017 Apr 7. J Lipid Res. 2017. PMID: 28389477 Free PMC article. Review.

4

The role of APOE in transgenic mouse models of AD.

Balu D, Karstens AJ, Loukenas E, Maldonado Weng J, York JM, Valencia-Olvera AC, LaDu MJ. Balu D, et al. Among authors: valencia olvera ac. Neurosci Lett. 2019 Aug 10;707:134285. doi: 10.1016/j.neulet.2019.134285. Epub 2019 May 28. Neurosci Lett. 2019. PMID: 31150730 Free PMC article. Review.

5

Role of estrogen in women's Alzheimer's disease risk as modified by APOE.

Valencia-Olvera AC, Maldonado Weng J, Christensen A, LaDu MJ, Pike CJ. Valencia-Olvera AC, et al. J Neuroendocrinol. 2023 Feb;35(2):e13209. doi: 10.1111/jne.13209. Epub 2022 Nov 24. J Neuroendocrinol. 2023. PMID: 36420620 Free PMC article. Review.

6

A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice.

Balu D, Valencia-Olvera AC, Nguyen A, Patnam M, York J, Peri F, Neumann F, LaDu MJ, Tai LM. Balu D, et al. Among authors: valencia olvera ac. Alzheimers Res Ther. 2023 Oct 19;15(1):181. doi: 10.1186/s13195-023-01330-6. Alzheimers Res Ther. 2023. PMID: 37858252 Free PMC article.

7

APOE genotype and sex modulate Alzheimer's disease pathology in aged EFAD transgenic mice.

Balu D, Valencia-Olvera AC, Islam Z, Mielczarek C, Hansen A, Perez Ramos TM, York J, LaDu MJ, Tai LM. Balu D, et al. Among authors: valencia olvera ac. Front Aging Neurosci. 2023 Oct 31;15:1279343. doi: 10.3389/fnagi.2023.1279343. eCollection 2023. Front Aging Neurosci. 2023. PMID: 38020764 Free PMC article.

8

Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease.

Mast N, Saadane A, Valencia-Olvera A, Constans J, Maxfield E, Arakawa H, Li Y, Landreth G, Pikuleva IA. Mast N, et al. Neuropharmacology. 2017 Sep 1;123:465-476. doi: 10.1016/j.neuropharm.2017.06.026. Epub 2017 Jun 24. Neuropharmacology. 2017. PMID: 28655608 Free PMC article.

9

Estradiol improves behavior in FAD transgenic mice that express APOE3 but not APOE4 after ovariectomy.

Balu D, Valencia-Olvera AC, Deshpande A, Narayanam S, Konasani S, Pattisapu S, York JM, Thatcher GRJ, LaDu MJ, Tai LM. Balu D, et al. Among authors: valencia olvera ac. Front Endocrinol (Lausanne). 2024 Apr 29;15:1374825. doi: 10.3389/fendo.2024.1374825. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38742194 Free PMC article.

10

APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-β42 Levels in Non-Hyperlipidemic Mice.

Valencia-Olvera AC, Balu D, Moore A, Shah M, Ainis R, Xiang B, Saleh Y, Cai D, LaDu MJ, Tai LM. Valencia-Olvera AC, et al. J Alzheimers Dis. 2024;97(4):1629-1639. doi: 10.3233/JAD-231210. J Alzheimers Dis. 2024. PMID: 38306049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page